The Desmoid Tumor Research Foundation

About DTRF

News & Updates

Stay Up to Date

Join The DTRF Newsletter

Join the Clinicians & Researchers Newsletter

OGSIVEO FDA-Approval Featured Image

Featured News

FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.

Read More about FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.

Filter by:

Clinical Trials

December 20, 2018

DTRF Press Release – DTRF’s Efforts Enable Largest Clinical Study On Desmoid Tumors (And More)

Read More about DTRF Press Release – DTRF’s Efforts Enable Largest Clinical Study On Desmoid Tumors (And More)